Peptide Therapeutics intermediate
Lung Cancer: Oligopeptide Research Reference
NSCLC (85%): adenocarcinoma, squamous cell, large cell. SCLC (15%): aggressive neuroendocrine. Molecular targets: EGFR, ALK, ROS1, BRAF, KRAS G12C, MET, RET,...
By Encyclopeptide Editorial | 1 min read
lung-cancer peptide research
Overview
NSCLC (85%): adenocarcinoma, squamous cell, large cell. SCLC (15%): aggressive neuroendocrine. Molecular targets: EGFR, ALK, ROS1, BRAF, KRAS G12C, MET, RET,…apy (pembrolizumab, atezolizumab), targeted therapy (osimertinib, alectinib).
Clinical Significance
This molecule has important therapeutic or diagnostic applications in clinical medicine.
References
- Encyclopeptide Database. “Lung Cancer” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Lung Cancer: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept